Schmidt M, Koller R, Haviernik P, Bies J, Maciag K, Wolff L
Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD, USA.
Oncogene. 2001 Sep 27;20(43):6205-14. doi: 10.1038/sj.onc.1204821.
Deregulated expression of the proto-oncogene c-myb, which results from provirus integration, is thought to be responsible for transformation in a set of murine leukemia virus (MuLV)-induced myeloid leukemias (MML). We reported recently that this transcription factor promotes proliferation by directly transactivating c-myc and inhibits cell death through its up-regulation of Bcl-2 (Schmidt et al., 2000). To understand more about how these cells become transformed we looked at how they deal with cellular pathways inducing growth arrest. Specifically, we were interested in the expression of the tumor suppressor gene Cdkn2b (p15(INK4b)) in MML because this gene is expressed during myeloid differentiation and its inactivation by methylation has been shown to be important for the development of human acute myeloid leukemia. mRNA levels for p15(INK4b) and another INK4 gene p16(INK4a) were examined in monocytic Myb tumors and were compared with expression of the same genes in c-myc transformed monocytic tumors that do not express c-Myb. The Cdkn2a (p16(INK4a)) gene was generally not expressed in either tumor type, an observation explained by methylation or deletion in the promoter region. Although Cdkn2b (p15(INK4b)) mRNA was expressed in the Myc tumors, many transcripts were aberrant in size and contained only exon 1. Surprisingly, in the majority of the Myb tumors there was no p15(INK4b) transcription and neither deletion nor methylation could explain this result. Additional experiments demonstrated that, in the presence of constitutive c-Myb expression, the induction of p15(INK4b) mRNA that accompanies differentiation of M1 cells to monocytes does not occur. Therefore, the transcriptional regulator c-Myb appears to prevent activation of a growth arrest pathway that normally accompanies monocyte maturation.
原癌基因c-myb的表达失调是由前病毒整合导致的,被认为与一组鼠白血病病毒(MuLV)诱导的髓性白血病(MML)的转化有关。我们最近报道,这种转录因子通过直接反式激活c-myc促进增殖,并通过上调Bcl-2抑制细胞死亡(施密特等人,2000年)。为了更深入了解这些细胞是如何发生转化的,我们研究了它们如何应对诱导生长停滞的细胞途径。具体来说,我们对MML中肿瘤抑制基因Cdkn2b(p15(INK4b))的表达感兴趣,因为该基因在髓系分化过程中表达,并且其因甲基化而失活已被证明对人类急性髓性白血病的发展很重要。在单核细胞性Myb肿瘤中检测了p15(INK4b)和另一个INK4基因p16(INK4a)的mRNA水平,并将其与不表达c-Myb的c-myc转化单核细胞性肿瘤中相同基因的表达进行了比较。Cdkn2a(p16(INK4a))基因在这两种肿瘤类型中通常都不表达,这一现象可通过启动子区域的甲基化或缺失来解释。虽然Cdkn2b(p15(INK4b))mRNA在Myc肿瘤中表达,但许多转录本大小异常,仅包含外显子1。令人惊讶的是,在大多数Myb肿瘤中没有p15(INK4b)转录,缺失和甲基化都无法解释这一结果。额外的实验表明,在组成型c-Myb表达的情况下,M1细胞向单核细胞分化时伴随的p15(INK4b)mRNA诱导不会发生。因此,转录调节因子c-Myb似乎阻止了正常伴随单核细胞成熟的生长停滞途径的激活。